dbDNA enables first UK patient dosing in lung cancer
The patient with advanced lung cancer received a personalised vaccine in the NEOVACC Phase I trial, aiming to boost immune recognition of tumour cells.
See the latest news and media coverage for BIA. We track all announcements, press releases, and industry mentions in real time, all in one place.
Trade association for UK biotech and life sciences
bioindustry.orgLast updated
In short: BIA reported record-breaking UK biotech financing in Q2 2026, reaching a five-year high of £2.1 billion as venture capital surged.
The patient with advanced lung cancer received a personalised vaccine in the NEOVACC Phase I trial, aiming to boost immune recognition of tumour cells.
The blog covers ongoing engagement with new government, farewell to Lord Vallance, and a Q2 funding milestone.
The round was co-led by Oxford Science Enterprises and Supernova Invest, with new and existing investors supporting the agricultural biotech company.
UK biotech venture capital reached £2.11 billion, with Isomorphic Labs' £1.6B Series B, but underlying market also doubled.
While UK biotech financing recovery is present in the private markets, BIA CEO Chris Molloy notes that UK public sector backing is essential for sustained...
Former Moderna executive Dr Melanie Ivarsson has been appointed chief executive of the UK's Health Data Research Service (HDRS), the centralised unit tasked with unlocking...
(Sharecast News) - Drug development company Redx Pharma noted an announcement from the UK BioIndustry Association (BIA) on Monday that Lisa Anson had been elected...
The UK Bioindustry Association (BIA) has been granted permission by the Supreme Court to intervene in its review of Warner-Lambert Company LLC v Generics (UK...
Track BIA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.